Urogen Pharma Ltd Share Price

NASDAQ: URGN

Small Cap

$18.33

+0.27

(+1.50%)

Live

as on September 17, 2025 at 12:40 am IST

$₹

Urogen Pharma Ltd Stock Performance

as on September 17, 2025 at 12:40 am IST

Day's Low
Day's High
$18.02
Day's Price Range
$18.75
$18.33
1.69%
Downside
2.29%
Upside
52 Week's Low
52 Week's High
$3.42
52-Week Price Range
$21.71
$18.33
81.34%
Downside
18.44%
Upside

Urogen Pharma Ltd share price movements today

Previous Close: $18.06
Open: $18.02
Volume: 915.4K
Day's Low - High: $18.02 - $18.75
52 Week Low - High: $3.42 - $21.71

Urogen Pharma Ltd Historical Returns

1 Month Return: -8.37 %
3 Month Return: + 25.94 %
1 Year Return: + 36.82 %
3 Year Return: + 107.11 %
5 Year Return: -19.3 %

Urogen Pharma Ltd Stock Fundamentals & Key Indicators

Check Urogen Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$869.3M

EPS (TTM)

-2.9929

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-122.2M

Revenue (TTM)

94.2M

Profit Margin

-164.44%

Return On Equity TTM

36760500.00%

Urogen Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Urogen Pharma Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Urogen Pharma Ltd	BUY	$869.3M	-19.3%	NA	-164.44%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Urogen Pharma Ltd Stock including INR - Dollar returns

The Urogen Pharma Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Urogen Pharma Ltd investment value today

Current value as on today

₹1,43,731

Returns

₹43,731

(+43.73%)

Returns from Urogen Pharma Ltd Stock

₹38,864 (+38.86%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Urogen Pharma Ltd Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Urogen Pharma Ltd. Average target price of $33.75

Urogen Pharma Ltd Share Price Target

Get share price movements and forecasts by analysts on Urogen Pharma Ltd.

What analysts predicted

45.69%UPSIDE

Target Price

$33.75

Current Price

$18.33

Analyzed by

11 Analysts

Target

$33.75

Urogen Pharma Ltd target price $33.75, a slight upside of 45.69% compared to current price of $18.33. According to 11 analysts rating.

Urogen Pharma Ltd Stock's Interest Amongst Investors

Search interest for Urogen Pharma Ltd Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-48% versus previous 30 day period

Urogen Pharma Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	17	21	20	23	18	21	25	24	20	24
Gross Profit	14	18	18	21	17	19	22	22	17	20
Operating Income	-22	-15	-13	-14	-25	-25	-17	-27	-36	-41
EBITDA	-26	-14	-12	-7	-23	-25	-14	-24	-36	-41
Interest Expense	3	3	3	3	2	3	2	3	8	8
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-30	-24	-21	-22	-32	-33	-23	-34	-43	-48
Income Tax Expense	0	0	0	3	0	0	0	2	0	1
Net Income	-30	-24	-21	-26	-32	-33	-23	-37	-43	-49
Net Profit Margin	-175.74%	-114.18%	-104.93%	-110.57%	-171.91%	-152.89%	-93.93%	-152.71%	-216.47%	-206.24%

Urogen Pharma Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	17	8	1	0	11	48	64	82	90
Gross Profit	0	17	7	0	0	10	42	56	73	81
Operating Income	-12	0	-19	-77	-109	-126	-92	-79	-65	-96
EBITDA	-12	1	-19	-76	-108	-124	-90	-76	-60	-110
Interest Expense	-	-	-	-	0	3	17	8	14	12
Depreciation	-	-	0	0	1	2	1	1	1	1
Income Before Tax	-12	-1	-19	-75	-105	-125	-109	-108	-98	-124
Income Tax Expense	-	-	0	0	-4	3	1	1	3	2
Net Income	-12	-1	-20	-75	-105	-128	-110	-109	-102	-126
Net Profit Margin	0.00%	-11.07%	-245.16%	-6707.18%	-584144.44%	-1088.94%	-230.67%	-170.58%	-123.61%	-140.35%

Urogen Pharma Ltd Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-24	-21	-26	-32	-33	-23	-37	-43	-49
Operating Cash Flow	-20	-17	-13	-31	-23	-27	-13	-42	-39
Investing Cash Flow	3	0	-11	13	11	-106	60	-25	28
Financing Cash Flow	0	116	0	54	100	39	0	0	0
Change in Cash	-16	99	-24	36	88	-94	47	-67	-11

Urogen Pharma Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	-20	-75	-105	-128	-110	-109	-102	-126
Operating Cash Flow	4	-9	-37	-71	-105	-84	-87	-76	-96
Investing Cash Flow	0	-36	35	-145	93	4	1	0	-20
Financing Cash Flow	0	61	66	165	16	72	97	116	194
Change in Cash	3	15	64	-51	3	-8	10	39	77

Global Institutional Holdings in Urogen Pharma Ltd

Funds	Holdings
UBS Asset Mgmt Americas Inc	9.44%
RTW INVESTMENTS, LLC	8.3%
RA Capital Management, LLC	6.94%
BlackRock Inc	5.25%
MENORA MIVTACHIM HOLDINGS LIMITED	4.98%

See all

Insights on Urogen Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 20.25M → 24.21M (in $), with an average increase of 16.4% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 33.8%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 9.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -23.67M → -49.94M (in $), with an average decrease of 29.8% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, URGN stock has moved down by -12.7%

About Urogen Pharma Ltd

urogen pharma ltd. (nasdaq:urgn) is a clinical-stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology, with a focus on uro-oncology. the company has developed rtgel™, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. urogen pharma's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. urogen pharma's lead product candidates, mitogel™ (mitomycin urothelial gel) and vesigel™ (mitomycin intravesical gel), are designed to potentially remove tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma and bladder cancer, respectively. urogen pharma is headquartered in ra’anana, israel with u.s. headquarters in new york.

Organisation	Urogen Pharma Ltd
Headquarters	400 Alexander Park Drive, Princeton, NJ, United States, 08540
Industry	Health Technology
CEO	Ms. Elizabeth A. Barrett
E-voting on shares	Click here to vote

Key Management of Urogen Pharma Ltd

Name	Title
Ms. Elizabeth A. Barrett	President, CEO & Director
Mr. Christopher Degnan CPA	Chief Financial Officer
Mr. Vincent I. Perrone	Senior Director of Investor Relations
Mr. Bryon Wornson	Executive Vice President of Talent, Advocacy & Communications
Dr. Mark P. Schoenberg M.D.	Chief Medical Officer
Mr. Jason Drew Smith J.D.	General Counsel, Chief Compliance Officer & Corporate Secretary
Dr. Marina Konorty Ph.D.	Executive Vice President of Research & Development and Technical Operations
Mr. James Ottinger R.ph.	Executive Vice President of Regulatory Affairs & Quality
Mr. Michael J. Louie M.D., M.P.H., M.Sc.	Executive Vice President of Medical Affairs & Clinical Development
Mr. David Lin	Chief Commercial Officer

FAQs

What is Urogen Pharma Ltd share price today?

Urogen Pharma Ltd share price today is $18.33 as on September 17, 2025 at 12:40 am IST. Urogen Pharma Ltd share today touched a day high of $18.75 and a low of $18.02.

What is the 52 week high and 52 week low for Urogen Pharma Ltd share?

Urogen Pharma Ltd share touched a 52 week high of $21.71 on September 8, 2025 and a 52 week low of $3.42 on May 21, 2025. Urogen Pharma Ltd stock price today i.e. September 17, 2025 at 12:40 am IST is trending at $18.33,which is 15.57% down from its 52 week high and 435.96% up from its 52 week low.

What is Urogen Pharma Ltd's market capitalisation today?

Urogen Pharma Ltd market capitalisation is $0.00T as on September 17, 2025 at 12:40 am IST.

How to invest in Urogen Pharma Ltd Stock (URGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Urogen Pharma Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Urogen Pharma Ltd Shares that will get you 0.0818 shares as per Urogen Pharma Ltd share price of $18.33 per share as on September 17, 2025 at 12:40 am IST.

What is the minimum amount required to buy Urogen Pharma Ltd Stock (URGN) from India?

Indian investors can start investing in Urogen Pharma Ltd (URGN) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 12:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Urogen Pharma Ltd stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 12:41 am IST). Based on Urogen Pharma Ltd share’s latest price of $18.33 as on September 17, 2025 at 12:40 am IST, you will get 0.5456 shares of Urogen Pharma Ltd. Learn more about fractional shares .

What are the returns that Urogen Pharma Ltd has given to Indian investors in the last 5 years?

Urogen Pharma Ltd stock has given -19.3% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?